Netupitant | List of Frontiers open access articles

Original Research

Published on 04 Aug 2016

Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs

in Cardiovascular and Smooth Muscle Pharmacology

Stefano Palea
Véronique Guilloteau
Moéz Rekik
Emanuela Lovati
Marc Guerard
Maria-Alba Guardia
Philippe Lluel
Claudio Pietra
Mitsuharu Yoshiyama

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00234

4,908 views
6 citations

Original Research

Published on 31 Aug 2016

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew)

in Pharmacology of Anti-Cancer Drugs

John A. Rudd
Man P. Ngan
Zengbing Lu
Guy A. Higgins
Claudio Giuliano
Emanuela Lovati
Claudio Pietra

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00263

6,664 views
25 citations

Original Research

Published on 31 Jul 2024

Safety assessment of neurokinin-1 receptor antagonist: real-world adverse event analysis from the FAERS database

in Drugs Outcomes Research and Policies

Chuanli Yang
Pengyang Xu
Teng Wu
Yunhe Fan
Qingqing Li
Jijun Zhang
Xiaobing Shen
Xiushan Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413709

5,577 views
4 citations

Review

Published on 30 Jan 2017

Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management

in Pharmacology of Anti-Cancer Drugs

Bernardo L. Rapoport

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00019

41,615 views
94 citations

Original Research

Published on 21 Nov 2023

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

in Hematologic Malignancies

Hang Zhang
Qiang Zeng
Tian Dong
Xinchuan Chen
Pu Kuang
Jian Li
Qiuhui Wu
Ting Liu
Ting Niu
Zhigang Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1280336

2,974 views
2 citations

Original Research

Published on 14 Feb 2023

RNA sequencing least shrew (Cryptotis parva) brainstem and gut transcripts following administration of a selective substance P neurokinin NK1 receptor agonist and antagonist expands genomics resources for emesis research

in RNA

Kristopher J. L. Irizarry
Weixia Zhong
Yina Sun
Brent A. Kronmiller
Nissar A. Darmani

Frontiers in Genetics

doi 10.3389/fgene.2023.975087

3,573 views
3 citations

Original Research

Published on 11 Mar 2024

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice

in Breast Cancer

Giulia Notini
Matteo Maria Naldini
Lorenzo Sica
Giulia Viale
Alessia Rognone
Stefania Zambelli
Patrizia Zucchinelli
Marta Piras
Carlo Bosi
Marco Mariani

Frontiers in Oncology

doi 10.3389/fonc.2024.1374547

8,688 views
9 citations

Original Research

Published on 06 Aug 2018

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)

in Translational Pharmacology

John A. Rudd
Sze W. Chan
Man P. Ngan
Longlong Tu
Zengbing Lu
Claudio Giuliano
Emanuela Lovati
Claudio Pietra

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00869

6,180 views
18 citations

Articles

Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew)

Safety assessment of neurokinin-1 receptor antagonist: real-world adverse event analysis from the FAERS database

Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

RNA sequencing least shrew (Cryptotis parva) brainstem and gut transcripts following administration of a selective substance P neurokinin NK1 receptor agonist and antagonist expands genomics resources for emesis research

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)